Built for CROs, CDMOs & life-science teams

Get a dedicated life science lead generation team.

We build a healthier pipeline for CRO's, CDMOs and tool providers at less than the cost of one internal hire. Call, qualify, and book the decision makers who matter.

★★★★★

Trusted by life-science commercial teams

5.2 avg. meetings / month
Live campaign signal
Pipeline overview

September campaign

Conversations48+18%
Qualified16+24%
Meetings7+2 this week
MC
Maya ChenVP, Clinical Development · qualified
Meeting booked
“Accel Bio turned wasted outreach into a steady stream of qualified meetings with biopharma decision makers.”

Vice President of Business DevelopmentGlobal CDMO

WHO WE SERVE

Specialized outreach for life science companies

ILLUSTRATIVE CAMPAIGN VIEWLIVE SEGMENT
ACTIVE MARKET

Finding opportunities for CDMOs

184matched accounts
623decision makers
31priority signals
PRIORITY OPPORTUNITY Strong fit

Sterile fill-finish partner for an upcoming Phase II program

Intent signalPartner shortlist expected to open this quarter
Qualified engagementLast 10 weeks
PHONE-FIRST OUTREACH

Real conversations beat crowded inboxes.

Our specialists pair research-led targeting with thoughtful phone outreach. Every call creates market intelligence—even when it does not create a meeting.

  • Native industry fluency
  • Human, context-rich conversations
  • Objection and intent capture
Chat with our team
01

ResearchAccount mapped

03

QualifyNeed confirmed

04

BookMeeting secured

LIVE CONVERSATION
MC

Dr. Maya Chen

VP, Clinical Development

08:42
MuteNotes
Intent signal capturedAnalytical transfer partner needed in Q4
A COMPLETE OUTBOUND TEAM

Reach life-science buyers reliably and at scale.

Your dedicated team handles the work between market definition and the first qualified meeting.

01

Consistent results

A reliable flow of qualified conversations, with campaigns tuned to your commercial goals.

Included as standard
02

Industry fluency

Specialists who understand development stages, modalities, service lines, and scientific buyers.

Included as standard
03

End-to-end management

Research, positioning, outreach, qualification, and scheduling—handled by one dedicated team.

Included as standard
04

Strategic targeting

Every account and contact is mapped against your ICP before a conversation begins.

Included as standard
05

Transparent reporting

See activity, conversations, objections, and meetings without digging through spreadsheets.

Included as standard
06

Lower-risk growth

Expand your commercial reach without the cost and management load of another internal hire.

Included as standard
COMMERCIAL TEAMS, ACCELERATED

Built for the realities of life-science growth.

Accel Bio completely changed our top-of-funnel strategy. Their specialized approach turned previously wasted efforts into a steady stream of qualified meetings.
2.1×qualified pipeline growth
★★★★★

The quality of meetings has been exceptional—prospects arrive with active needs in our service areas.

Director, Business DevelopmentClinical-stage CDMO
★★★★★

Our BD team can focus entirely on meaningful discussions and closing because the prospecting is handled.

Chief Commercial OfficerGlobal CDMO
ENGAGEMENT PLANS

Choose the outbound team that fits your growth plan.

Start with focused lead generation or expand into a full inside-sales function. We’ll tailor the right engagement around your market, team, and goals.

Flexible engagement

Lead Generation Package

A focused, phone-first program for teams that need qualified meetings without adding internal headcount.

Dedicated SDRResearcherCampaign manager
  • Unlimited contacts per month
  • Up to 400 calls per day
  • Month-to-month contract
  • Weekly or bi-weekly meetings
  • North American and European markets
  • Personalized SMS follow-ups and reminders
  • Optional full sales-cycle follow-up
YOUR NEXT CONVERSATION STARTS HERE

Put your growth plan in motion.

Tell us who you need to reach. We’ll show you how Accel Bio can get the conversation started.

Chat with our team 30-minute working session · no hard sell